Amicogen Inc
KOSDAQ:092040
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Amicogen Inc
Accrued Liabilities
Amicogen Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Amicogen Inc
KOSDAQ:092040
|
Accrued Liabilities
₩2.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
14%
|
|
|
Celltrion Inc
KRX:068270
|
Accrued Liabilities
₩191.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Accrued Liabilities
₩52.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Accrued Liabilities
₩449.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Accrued Liabilities
₩375m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
18%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Accrued Liabilities
₩462.2m
|
CAGR 3-Years
36%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Amicogen Inc
Glance View
Amicogen, Inc. engages in the development and sale of enzyme products and functional food materials. The company is headquartered in Jinju, Gyeongsangnam-Do. The company went IPO on 2013-09-12. The Company’s products consist of special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins. The firm distributes its products within domestic market and to overseas markets, including China, Japan, the United Sates, Germany and Thailand.
See Also
What is Amicogen Inc's Accrued Liabilities?
Accrued Liabilities
2.9B
KRW
Based on the financial report for Dec 31, 2025, Amicogen Inc's Accrued Liabilities amounts to 2.9B KRW.
What is Amicogen Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
14%
Over the last year, the Accrued Liabilities growth was -12%. The average annual Accrued Liabilities growth rates for Amicogen Inc have been -15% over the past three years , -9% over the past five years , and 14% over the past ten years .
